Filing Details
- Accession Number:
- 0001209191-19-007770
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-06 16:49:36
- Reporting Period:
- 2019-02-04
- Accepted Time:
- 2019-02-06 16:49:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Interim Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-04 | 809 | $86.52 | 16,896 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-04 | 809 | $189.19 | 16,087 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-04 | 600 | $185.11 | 15,487 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-04 | 450 | $186.17 | 15,037 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-04 | 2,268 | $186.85 | 12,769 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-04 | 120 | $188.33 | 12,649 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-02-04 | 809 | $0.00 | 809 | $86.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,472 | 2027-02-02 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $185.11 (range $184.54 to $185.49).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $186.17 (range $185.74 to $186.52).
- Open market sales reported on this line occurred at a weighted average price of $186.85 (range $186.62 to $187.33).
- Open market sales reported on this line occurred at a weighted average price of $188.33 (range $188.25 to $188.35).
- The option vests in 16 quarterly installments from 02/03/2017.
Billionaire Hedge Funds
